A breakthrough in understanding the pathogenesis of LCH occurred in 2010 when a gain-of-function mutation in B-RAF (V600E) was identified in more than half of LCH patient samples [21]. This evidence concerns the gene BRAF and Langerhans cell histiocytosis.